Trial Profile
Clinical Trials Insight: 700028175
Status:
Suspended
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2007
Price :
$35
*
At a glance
- Drugs Thymalfasin (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- Sponsors SciClone Pharmaceuticals
- 06 Nov 2007 New trial record.